insights_auto
Why is MOLBIO down 2.50%?
Dive Deeperchevron_right
MOLBIO:NSE
Molbio Diagnostics Limited
₹1,270.00
arrow_downward
-2.50%(-32.60) 1D
Oct 30, 3:30:02 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLBIO...
Open
₹1,315.00
High
₹1,345.00
Low
₹1,262.60
Mkt. cap
146.78B
Avg. vol.
2.00M
Volume
547.91K
P/E ratio
85.96
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Open
₹1,315.00
High
₹1,345.00
Low
₹1,262.60
Mkt. cap
146.78B
Avg. vol.
2.00M
Volume
547.91K
P/E ratio
85.96
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
News stories
From web sources and news partners
https://tech-insider.org/
·
21 minutes ago
AI Capex Boom: $828B Spend, Nasdaq Down 2.9% [2026]
Istituto Impariamo
·
39 minutes ago
Nasdaq Futures Surge as Big Tech AI Demand Unleashes Massive Liquidity Rally
www.tokenpost.com
·
1 hour ago
Nasdaq Falls 2.86% as U.S. Markets Enter Election and Earnings Week
Bloomberg.com
·
53 minutes ago
Asian Stocks to Fall as Tech Rout Fuels AI Fears: Markets Wrap
Profile
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis.
The Truenat platform is recognized by the World Health Organization for the initial detection of tuberculosis and rifampicin resistance. Following clinical studies, including research published in The Lancet, the technology has been adopted by national health programs in over 85 countries.
In 2025, Molbio was awarded the Kochon Prize by the Stop TB Partnership, the world's largest award for tuberculosis. Wikipedia
About Molbio Diagnostics Limited